This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

ARTIALIS

Thank you for visiting our virtual exhibit

ARTIALIS


COMPANY BACKGROUND
Integrating scientific expertise and support for research, Artialis is your specialized partner for product development in rheumatology and musculoskeletal diseases from preclinical studies (in vitro and in vivo) to clinical trials.

ADDED VALUE
Artialis is able to work all the path of product development from preclinical studies to clinical trials (Phase 1 to 4) to address unmet needs. Artialis is partner of choice for the development of therapeutic approaches (drug, medical device as well as food supplement) for biotech, pharma companies and food supplement/nutrition industry.


RANGE OF PRODUCTS
Preclinical services:
In vitro and In vivo tailor made efficacy studies - PD/PK - Imaging - Ex vivo testing (Histology, Biomarkers & Biomechanics)


CLINICAL SERVICES
Trial design and management (first-in-man to phase IV) - Protocol writing - KOL & Scientific board - Innovative markers - Site selection & management - Recruitment tools – Data monitoring - Data management & Biostatistics - Final report - Scientific Writing


BIOTESTING
Imaging and soluble biomarkers centralized platform
CERTIFICATION
ISO9001, GCP, GCLP 

 

CONTACT
Avenue de l’Hôpital, 11
GIGA B34 +3
4000 LIEGE
Tel : +32 42 42 77 27
E-mail: bd@artialis.com
Website: www.artialis.com
DELEGATE
Christelle BOILEAU, Chief Business Officer
Mobile: +32 474 82 77 22
E-mail: christelle.boileau@artialis.com